Varma Mutual Pension Insurance Co bought a new position in Corteva, Inc. (NYSE:CTVA - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 185,376 shares of the company's stock, valued at approximately $15,699,000.
A number of other institutional investors have also recently made changes to their positions in CTVA. JPL Wealth Management LLC bought a new stake in shares of Corteva during the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC bought a new position in Corteva in the 4th quarter valued at approximately $27,000. Bank of Jackson Hole Trust purchased a new stake in Corteva during the 4th quarter valued at $28,000. Cornerstone Financial Management LLC purchased a new stake in Corteva during the 4th quarter valued at $29,000. Finally, Elevation Wealth Partners LLC increased its holdings in shares of Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company's stock worth $29,000 after purchasing an additional 261 shares in the last quarter. Hedge funds and other institutional investors own 81.54% of the company's stock.
Wall Street Analyst Weigh In
CTVA has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $101.00 price target on shares of Corteva in a research note on Monday, August 3rd. Zacks Research downgraded Corteva from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 11th. CICC Research boosted their target price on Corteva from $80.00 to $93.00 and gave the stock an "outperform" rating in a research report on Wednesday, May 13th. UBS Group lowered their target price on shares of Corteva from $89.00 to $85.00 and set a "neutral" rating on the stock in a research note on Tuesday, August 18th. Finally, Mizuho raised their price target on shares of Corteva from $96.00 to $97.00 and gave the company an "outperform" rating in a report on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. Based on data from MarketBeat.com, Corteva presently has an average rating of "Moderate Buy" and an average price target of $91.50.
Read Our Latest Report on Corteva
Corteva Stock Up 0.1%
Shares of CTVA opened at $81.84 on Monday. The business's 50 day moving average is $82.13 and its 200 day moving average is $80.26. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97. The company has a market capitalization of $54.60 billion, a PE ratio of 54.20, a price-to-earnings-growth ratio of 2.51 and a beta of 0.57.
Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm's revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the prior year, the company posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.
Corteva Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva's dividend payout ratio (DPR) is presently 47.68%.
Corteva Company Profile
(
Free Report)
Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
